Figure 3: MTS assay dose-response curves for treatment of HCT-15 cells by gendanamycin (a P-gp substrate drug) (A), oxaliplatin (B) or cisplain (C) in the presence or absence of P-gp inhibitor cyclosporine A (7.5 µM).